Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort

  1. Puigvehí, M.
  2. De Cuenca, B.
  3. Viu, A.
  4. Diago, M.
  5. Turnes, J.
  6. Gea, F.
  7. Pascasio, J.M.
  8. Lens, S.
  9. Cabezas, J.
  10. Badia, E.
  11. Olveira, A.
  12. Morillas, R.M.
  13. Torras, X.
  14. Montoliu, S.
  15. Cordero, P.
  16. Castro, J.L.
  17. Salmerón, J.
  18. Molina, E.
  19. Sánchez-Ruano, J.J.
  20. Moreno, J.
  21. Antón, M.D.
  22. Moreno, J.M.
  23. De la Vega, J.
  24. Calleja, J.L.
  25. Carrión, J.A.
Journal:
Liver International

ISSN: 1478-3231 1478-3223

Year of publication: 2019

Volume: 39

Issue: 1

Pages: 90-97

Type: Article

DOI: 10.1111/LIV.13950 GOOGLE SCHOLAR

Sustainable development goals